Literature DB >> 22205060

Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.

Derek Leroith1.   

Abstract

The worldwide obesity epidemic has brought to the author's attention the cardiometabolic risk factors and cardiovascular disease associated with the metabolic syndrome. The emphasis on diagnosing and treating the individual risk factors should help in the prevention of the cardiovascular disease associated with obesity, the metabolic syndrome and type 2 diabetes.

Entities:  

Mesh：

Year:  2012        PMID： 22205060     DOI： 10.1097/MAJ.0b013e31823ea214

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  21 in total

Review 1.  The role of adiponectin signaling in metabolic syndrome and cancer.

Authors:  Michael P Scheid; Gary Sweeney
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

Review 2.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

3.  Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair.

Authors:  Michael R Hall; Clinton D Protack; Roland Assi; Willis T Williams; Daniel J Wong; Daniel Lu; Bart E Muhs; Alan Dardik
Journal:  J Vasc Surg       Date:  2013-12-17       Impact factor: 4.268

Review 4.  Skin and metabolic syndrome: A review of the possible associations.

Authors:  Neda Adibi; Reza M Robati
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

5.  Pathophysiological insights into cardiovascular health in metabolic syndrome.

Authors:  Yingmei Zhang; James R Sowers; Jun Ren
Journal:  Exp Diabetes Res       Date:  2012-07-16

6.  Blood Pressure, Serum Glucose, Cholesterol, and Triglycerides in Dogs with Different Body Scores.

Authors:  Mauro José Lahm Cardoso; Rafael Fagnani; Carolina Zaghi Cavalcante; Marcelo de Souza Zanutto; Ademir Zacarias Júnior; Luciane Holsback da Silveira Fertonani; Jéssica Ragazzi Calesso; Maíra Melussi; Helena Pinheiro Costa; Eduardo Yudi Hashizume
Journal:  Vet Med Int       Date:  2016-12-12

7.  Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.

Authors:  Asta Tvarijonaviciute; Jose J Ceron; Shelley L Holden; Daniel J Cuthbertson; Vincent Biourge; Penelope J Morris; Alexander J German
Journal:  BMC Vet Res       Date:  2012-08-28       Impact factor: 2.741

8.  Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adults.

Authors:  Molly G Minze; Mary S Klein; Brian T Terrell
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-07-31

9.  Breakfast frequency and development of metabolic risk.

Authors:  Andrew O Odegaard; David R Jacobs; Lyn M Steffen; Linda Van Horn; David S Ludwig; Mark A Pereira
Journal:  Diabetes Care       Date:  2013-06-17       Impact factor: 19.112

Review 10.  Insulin-like growth factor-1 deficiency and metabolic syndrome.

Authors:  G A Aguirre; J Rodríguez De Ita; R G de la Garza; I Castilla-Cortazar
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.